m+Medelevator.RU
← Поиск публикаций
International journal of women's health · 2025

Clinical Characteristics of Non-Lactational Mastitis of Accessory Breast: A Case-Series Study.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zhao Di, Zhang Dongxiao, Zeng Yifei, Fu Na, Xu Xiaolong

Аннотация

BACKGROUND: Non-lactational Mastitis of Accessory Breast (NLM-AB) is a rare condition with limited research, leading to diagnostic challenges. Its clinical and demographic characteristics are poorly defined, and it is often confused with non-lactational mastitis (NLM), hindering effective diagnosis and treatment.

OBJECTIVE: This study aims to clarify the features of NLM-AB, distinguish it from NLM, and address key knowledge gaps to improve clinical diagnosis and patient management.

METHODS: We retrospectively analyzed data from 31 NLM-AB patients treated at Beijing Hospital of Traditional Chinese Medicine from January 2014 to September 2024. A 1:1 matched case-control study was conducted, comparing NLM-AB (case group) with 31 NLM patients (control group).

RESULTS: NLM-AB patients had a mean age of 36.68 ± 7.17 years and BMI of 23.10 ± 3.52. Most were married (83.87%) and had given birth (58.06%). All had axillary masses, with 85.19% showing skin changes. Statistically significant differences were found in marital status, reproductive history, breastfeeding duration, tumor size, and nipple retraction (P < 0.05). No significant differences were observed in nipple discharge, ulcer occurrence, or prolactin levels (P > 0.05).

CONCLUSION: This study addresses a key clinical gap by identifying distinguishing features of NLM-AB, such as consistent axillary masses without nipple retraction and associations with reproductive history. These findings can directly support clinicians in early recognition and differential diagnosis of NLM-AB, avoiding unnecessary interventions targeting primary breast tissue. Incorporating these patient characteristics into diagnostic pathways may reduce misdiagnosis rates and guide more tailored treatment strategies, ultimately improving patient outcomes.